Abstract
Importance Seasonal influenza hospitalizations pose a considerable burden in the United States, with BIPOC (Black, Indigenous, and other People of Color) communities being disproportionately affected.
Objective To determine and quantify the effects of different types of mitigation strategies on inequities in influenza outcomes (symptomatic infections and hospitalizations).
Design In this simulation study, we fit a race-stratified agent-based model of influenza transmission to demographic and hospitalization data of the United States.
Participants We consider five racial-ethnic groups: non-Hispanic White persons, non-Hispanic Black persons, non-Hispanic Asian persons, non-Hispanic American Indian or Alaska Native persons, and Hispanic or Latino persons.
Setting We tested five idealized equity-promoting interventions to determine their effectiveness in reducing inequity in influenza outcomes. The interventions assumed (i) equalized vaccination rates, (ii) equalized comorbidities, (iii) work-risk distribution proportional to the distribution of the population, (iv) reduced work contacts for all, or (v) a combination of equalizing vaccination rates and comorbidities and reducing work contacts.
Main Outcomes and Measures Reduction in symptomatic or hospitalization risk ratios, defined as the ratio of the number of symptomatic infections (hospitalizations respectively) in each age- and racial-ethnic group and their corresponding white counterpart. We also evaluated the reduction in the absolute mean number of symptomatic infections or hospitalizations in each age- and racial-ethnic group compared to the fitted scenario (baseline).
Results Our analysis suggests that symptomatic infections were equalized and reduced (by up to 17% in BIPOC adults aged 18-49) by strategies reducing work contacts or equalizing vaccination rates. Reducing comorbidities resulted in significant decreases in hospitalizations, with a reduction of over 40% in BIPOC groups. All tested interventions reduced the inequity in influenza hospitalizations in all racial-ethnic groups, but interventions reducing comorbidities in marginalized populations were the most effective. Notably, these interventions resulted in better outcomes across all racial-ethnic groups, not only those prioritized by the interventions.
Conclusions and Relevance In this simulation modeling study, equalizing vaccination rates and reducing number of work contacts (which are relatively simple strategies to implement) reduced the both the inequity in hospitalizations and the absolute number of symptomatic infections and hospitalizations in all age and racial-ethnic groups.
Question What interventions might be effective in reducing the observed race-based disparities in seasonal influenza hospitalizations in the United States (US)?
Findings Simulated interventions equalizing comorbidity rates by in marginalized racial-ethnic groups would prevent up to 40% hospitalizations in these groups. Increasing vaccination rates among marginalized communities or reducing work contacts would reduce hospitalizations by over 10% and 20%, respectively, in most racial-ethnic groups and would similarly reduce symptomatic infections.
Meaning Increasing vaccination rates among marginalized communities, decreasing comorbidities in these groups, or reducing work contacts would help reduce the race-based disparities in seasonal influenza hospitalizations in the US.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by grants from the National Institutes of Health (UM1AI068635). L.M. and D.D. were also supported by a grant from Centers for Disease Con- trol and Prevention (NU38OT000297-02) through their cooperative agreement with the Council of State and Territorial Epidemiologists. L.M. was partially funded through the IDCRC Early Career Investigator Pilot Award subaward #A925844 (NIH # 5UM1AI148684-05). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Extended the abstract, moved methods section to the supplemental material
Data Availability
All data produced will be available online.
https://github.com/laura-matrajt/inequities_flu_hospitalizations
